Evidence map›Paper›PMID 37313807›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2023

[

Ziran Zhang, Jiale Tan, Zihang Yu, Chengdong Liu, Jian Wang, Dehua Wu, Xue Bai

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ziran ZhangNanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Jiale TanNanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Zihang YuNanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Chengdong LiuNanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Jian WangNanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Dehua WuNanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Xue BaiNanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Nanfang Hospital · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveImmunotherapy has brought significant clinical benefits to a subset of patients, but has thus far been disappointing in the treatment of immunologically "cold" tumors. Existing biomarkers that can precisely identify these populations are insufficient. In this context, a potential cold tumor microenvironment (TME) marker

methodsThe expression levels and mutational landscape of

results

conclusionThis study provides a pan-cancer landscape of the

Indexed as

Adenocarcinoma of LungLung NeoplasmsHumansPrognosisSequence Analysis, RNATumor MicroenvironmentDNA damage repairFARSBimmunotherapypan-cancertumor microenvironment

Identifiers

PMID37313807
PMCPMC10267241
OpenAlexW4380576696

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.